- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-249/24: Action brought on 13 May 2024 – Serana Europe v EUIPO – Cytogen Produkte für Medizin + Forschung (Amniogrow)
ECLI:EU:UNKNOWN:62024TN0249
62024TN0249
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C series
—
C/2024/3800
(Case T-249/24)
(C/2024/3800)
Language in which the application was lodged: German
Parties
Applicant: Serana Europe GmbH (Pessin, Germany) (represented by: T. Bösling and I. George, lawyers)
Defendant: European Union Intellectual Property Office
Other party to the proceedings before the Board of Appeal: Cytogen Produkte für Medizin + Forschung GmbH (Greven, Germany)
Details of the proceedings before EUIPO
Applicant for the trade mark at issue: Applicant
Trade mark at issue: Application for the EU trade mark Amniogrow – Application No 18 567 544
Proceedings before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 12 March 2024 in Case R 1705/2023-2
Form of order sought
The applicant claims that the Court should:
—amend the contested decision to the effect that the opposition filed by Cytogen Produkte für Medizin + Forschung GmbH against EU trade mark application No 18 567 544 ‘Amniogrow’ is rejected and the appellant before the Board of Appeal is ordered to pay the costs of the proceedings before the Board of Appeal;
—in the alternative, annul the contested decision;
—order EUIPO to pay the costs.
Plea in law
Infringement of Article 8(4) in conjunction with Article 71 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
—
ELI: http://data.europa.eu/eli/C/2024/3800/oj
ISSN 1977-091X (electronic edition)
—